[1] Xiao J, Wang F, Wong N K, et al. Global liver disease burdens and research trends: Analysis from a Chinese perspective. J Hepatol, 2019, 71: 212-221.
[2] Yan S, Huda N, Khambu B, et al. Relevance of autophagy to fatty liver diseases and potential therapeutic applications. Amino Acids, 2017, 49: 1965-1979.
[3] Ueno T, Komatsu M. Autophagy in the liver: functions in health and disease. Nat Rev Gastroenterol Hepatol, 2017, 14: 170-184.
[4] Onishi M, Yamano K, Sato M, et al. Molecular mechanisms and physiological functions of mitophagy. Embo J, 2021, 40: e104705.
[5] Dikic I, Elazar Z. Mechanism and medical implications of mammalian autophagy. Nat Rev Mol Cell Biol, 2018, 19: 349-364.
[6] Kim J, Kundu M, Viollet B, et al. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat Cell Biol, 2011, 13: 132-141.
[7] Mizushima N, Levine B. Autophagy in Human Diseases. N Engl J Med, 2020, 383: 1564-1576.
[8] Seitz HK, Bataller R, Cortez-Pinto H, et al. Alcoholic liver disease. Nat Rev Dis Primers,2018, 4: 16.
[9] Williams JA, Ding WX. Role of autophagy in alcohol and drug-induced liver injury. Food Chem Toxicol, 2020, 136: 111075.
[10] Menk M, Graw JA, Poyraz D, et al. Chronic Alcohol Consumption Inhibits Autophagy and Promotes Apoptosis in the Liver. Int J Med Sci, 2018, 15: 682-688.
[11] Chao X, Ni HM, Ding WX. Insufficient autophagy: a novel autophagic flux scenario uncovered by impaired liver TFEB-mediated lysosomal biogenesis from chronic alcohol-drinking mice. Autophagy, 2018, 14: 1646-1648.
[12] Babuta M, Furi I, Bala S, et al. Dysregulated Autophagy and Lysosome Function Are Linked to Exosome Production by Micro-RNA 155 in Alcoholic Liver Disease. Hepatology, 2019, 70: 2123-2141.
[13] Liu L, Xie P, Li W, et al. Augmenter of Liver Regeneration Protects against Ethanol-Induced Acute Liver Injury by Promoting Autophagy. Am J Pathol, 2019, 189: 552-567.
[14] 全敏, 段英, 邢卉春. 酒精性脂肪性肝病与细胞自噬研究进展. 中国肝脏病杂志(电子版), 2021, 13: 25-29.
[15] Schott MB, Weller SG, Schulze RJ, et al. Lipid droplet size directs lipolysis and lipophagy catabolism in hepatocytes. J Cell Biol, 2019, 218: 3320-3335.
[16] Younossi Z, Tacke F, Arrese M, et al. Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis. Hepatology, 2019, 69: 2672-2682.
[17] Martinez-Lopez N, Singh R. Autophagy and Lipid Droplets in the Liver. Annu Rev Nutr, 2015, 35: 215-237.
[18] Gao Y, Zhang W, Zeng LQ, et al. Exercise and dietary intervention ameliorate high-fat diet-induced NAFLD and liver aging by inducing lipophagy. Redox Biol, 2020, 36: 101635.
[19] Wu WKK, Zhang L, Chan MTV. Autophagy, NAFLD and NAFLD-Related HCC. Adv Exp Med Biol, 2018, 1061: 127-138.
[20] Ma X, Mckeen T, Zhang J, et al. Role and Mechanisms of Mitophagy in Liver Diseases. Cells, 2020, 9:837.?.
[21] Wang L, Liu X, Nie J, et al. ALCAT1 controls mitochondrial etiology of fatty liver diseases, linking defective mitophagy to steatosis. Hepatology, 2015, 61: 486-496.
[22] Li R, Xin T, Li D, et al. Therapeutic effect of Sirtuin 3 on ameliorating nonalcoholic fatty liver disease: The role of the ERK-CREB pathway and Bnip3-mediated mitophagy. Redox Biol, 2018, 18:229-243.
[23] Satriano L, Lewinska M, Rodrigues PM, et al. Metabolic rearrangements in primary liver cancers: cause and consequences. Nat Rev Gastroenterol Hepatol, 2019, 16: 748-766.
[24] Kimmelman AC, White E. Autophagy and Tumor Metabolism. Cell Metab, 2017, 25: 1037-1043.
[25] Jiao L, Zhang HL, Li DD, et al. Regulation of glycolytic metabolism by autophagy in liver cancer involves selective autophagic degradation of HK2 (hexokinase 2). Autophagy, 2018, 14: 671-684.
[26] Huang X, Gan G, Wang X, et al. The HGF-MET axis coordinates liver cancer metabolism and autophagy for chemotherapeutic resistance. Autophagy, 2019, 15: 1258-1279.
[27] Stravitz RT, Lee WM. Acute liver failure. Lancet, 2019, 394: 869-881.
[28] Allaire M, Rautou PE, Codogno P, et al. Autophagy in liver diseases: Time for translation?. J Hepatol, 2019, 70: 985-998.
[29] Hernaez R, Solà E, Moreau R, et al. Acute-on-chronic liver failure: an update. Gut, 2017, 66: 541-553.
[30] Xue R, Yang J, Jia L, et al. Mitofusin2, as a Protective Target in the Liver, Controls the Balance of Apoptosis and Autophagy in Acute-on-Chronic Liver Failure. Front Pharmacol, 2019, 10: 601.
[31] Yu Z, Li J, Ren Z, et al. Switching from Fatty Acid Oxidation to Glycolysis Improves the Outcome of Acute-On-Chronic Liver Failure. Adv Sci (Weinh), 2020, 7: 1902996. |
